Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

BMS-470539 reduces skin fibrosis and inflammation.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Pexidartinib often causes liver issues and fatigue, especially in women.

Compound 7p shows strong potential as an anticancer agent.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Baricitinib is not very effective for severe alopecia areata.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Baricitinib is an effective treatment for severe alopecia areata.